Clinical Trials
3
Active:0
Completed:3
Trial Phases
2 Phases
Phase 1:2
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)β’ Click on a phase to view related trials
Phase 1
2 (66.7%)Phase 2
1 (33.3%)Convalescent Plasma for Treatment of COVID-19
Phase 2
Completed
- Conditions
- Covid19
- First Posted Date
- 2020-12-02
- Last Posted Date
- 2022-02-09
- Lead Sponsor
- Joakim Dillner
- Target Recruit Count
- 59
- Registration Number
- NCT04649879
- Locations
- πΈπͺ
Department of Infectious Disease, Falu Hospital, Falun, Dalarn, Sweden
πΈπͺDepartment of Geriatrics, Karolinska University Hospital, Stockholm, Sweden
πΈπͺDanderyd Hospital, Stockholm, Sweden
Convalescent Plasma as Treatment for Acute Coronavirus Disease (COVID-19)
Phase 1
Completed
- Conditions
- COVID-19
- First Posted Date
- 2020-05-15
- Last Posted Date
- 2021-12-16
- Lead Sponsor
- Joakim Dillner
- Target Recruit Count
- 10
- Registration Number
- NCT04390178
- Locations
- πΈπͺ
Danderyd Hospital, Danderyd, Sweden
Convalescent Plasma for Treatment of COVID-19: An Exploratory Dose Identifying Study
Phase 1
Completed
- Conditions
- COVID-19
- First Posted Date
- 2020-05-12
- Last Posted Date
- 2021-12-03
- Lead Sponsor
- Joakim Dillner
- Target Recruit Count
- 10
- Registration Number
- NCT04384497
- Locations
- πΈπͺ
Danderyd Hospital, Danderyd, Stockholm, Sweden
πΈπͺKarolinska University Hospital, Stockholm, Sweden
News
No news found